Phase Holographics Imaging PHI AB
30 Mar - 13 Apr 2022Rights issue
After successful collaboration between the Competence Center for Circuit Design (CCCD) at Lund University and PHI’s founders resulting in M1, the first prototype of the HoloMonitor product line, PHI was founded in 2004.
PHI’s time-lapse cytometers are designed to non-invasively explore the kinetics of cellular responses, rather than just providing snapshots the way traditional endpoint assays do. PHI’s time-lapse cytometers are based on a novel technology – holographic microscopy – that automatically analyzes living cells in ways not previously possible.
The offer in summary
Record date: 24 March 2022
Subscription period: 30 March 2022 - 13 April 2022
Terms: One (1) previously owned share gives one (1) unit right. Seventeen (17) unit rights entitles the holder to subscribe for one (1) unit. Each unit consists of nine (9) newly issued shares, five (5) warrants of series TO 3, and two (2) warrants of series TO 4. The warrants are free of payment.
Subscription price: 85.50 SEK per unit
The offer: Rights issue of maximum 846 763 units, which corresponds to ca 72 MSEK.
Trading with unit rights: Until 8 April 2022
Marketplace: Spotlight Stock Market
Financial advisor: Sedermera Corporate Finance